Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-156658
Filing Date
2016-12-23
Accepted
2016-12-23 16:03:07
Documents
1
Period of Report
2016-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4871
  Complete submission text file 0001209191-16-156658.txt   6415
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 NUTCRACKER LANE ALISO VIEJO CA 92656
Business Address
Drazba Brian G. (Reporting) CIK: 0001507369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 162069055